Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testi...
Scoring cues
positive tone 1constructive context 2
Breakthrough researchCommunity impact